bpc-157 safety data human adverse events case report Data: Promising, But Not Proven In Humans, Early animal bpc 157 human clinical trials

Serious adverse effects have not been widely reported, but long-term safety data in humans is lacking

So while all estradiol is estrogen, not all estrogen is estradiol

As of February 23, 2026, Eli Lilly & Company has a promotion for the Zepbound Self Pay Journey Program, which lowers rates to $449 for each 1-month supply of the 7.5 mg, 10 mg, 12.5 mg, and 15 mg Zepbound single-dose vial or Zepbound KwikPen for single-patient-use

Metabolic Safety: IGF-1 and Glucose Effects One of the most clinically significant safety findings relates to AOD-9604s metabolic profile, particularly its lack of effects on insulin-like growth factor-1 (IGF-1) and glucose metabolism